Status:
UNKNOWN
HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population
Lead Sponsor:
ANRS, Emerging Infectious Diseases
Conditions:
Human Papillomavirus Infection
Human Immunodeficiency Virus Infection
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to estimate the prevalence of HPV infections anal and ENT level and according to HIV status in transgender (TG) population. The main question it aims to answer ...
Detailed Description
Context: The few publications with an individualized transgender (TG) population have been conducted in South America (Peru, Argentina) showing very high anal or ano-genital hrHPV prevalences of arou...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age ≥ 18 years
- To belong to transgender population : i.e. people who doesn't identify to the gender assigned at birth
- To be affiliated to a social security system or be beneficiary of AME
- Exclusion criteria:
- To have ever been vaccinated against HPV
- Research participation refusal
- People under guardianship or curatorship, or deprived of liberty by administrative or judiciary measure
Exclusion
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05981807
Start Date
October 1 2023
End Date
October 1 2024
Last Update
August 8 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.